|
Search Term: " Bronze "
What Makes Organic Raw Almonds so Good for My Health?   
Date:
April 16, 2011 10:10 AM
Eat Organic Raw Almonds for Good Health.
Almonds are widely cultivated for its nuts, which are rich in vitamins and minerals. Throughout history, almond nuts have enjoyed a significant presence in many cuisines from all over the world. In fact, they are one of the best known nuts, rivaled only by peanuts in popularity. In recent years, almond nuts have been tied to alkaline diet, which consists of healthy foods touted to be alkaline-forming. Prunus dulcis, the scientific name of almonds, is believed to have been domesticated earlier than the ancient times, with earliest evidence dating back to more than 2000 years ago in what is now known as the Early Bronze Age. This species is one of the ancient fruit-bearing trees grown commercially that remains popular to this day largely owing to its capacity to easily grow and bear fruits without the aid of grafting. Organic almonds are different from other almonds grown the conventional way in that, as the name suggests, they meet the standards for organic farming, a method of food production that does away with chemicals known for their potential threat to the human health. In addition to being the only nuts considered alkaline forming, it contains higher levels of bioactive compounds noted for their nutritional significance. Decreases Acidic By-Products Almond, the only alkalizing nut, works on the principle of rebalancing the body’s pH. Proponents of alkaline diet believe that foods that are identified to be alkaline-forming aid the body in maintaining homeostasis and restore pH imbalances in the human body. It follows that foods that are acid-forming gradually contribute to the formation of diseases. Organic almonds, guaranteed to contain none of the chemical compounds known to produce acidic by-products, help rebalance the overall pH of the body. Enhances Mental Performance
Prevents Many Known Diseases One cup of organic almonds is enough to meet the recommended daily intake for vitamin E and magnesium, two nutrients that have been the subject of extensive study in the past few years for their purported role in medicine. Vitamin E is an antioxidant that is pervasive at the cellular level. Magnesium improves health by raising the production of energy needed for cellular functions. Organic almonds have been linked to the treatment of many different diseases, such as diabetes, cardiovascular diseases, cancer, and digestive problems. More importantly, they are one of the sources of food consistently recommended by experts on the alkaline diet. Most importantly, raw almonds are full of nutrients and phytonutrients. Have you had your raw almonds today?
(https://vitanetonline.com:443/forums/Index.cfm?CFApp=1&Message_ID=2276) Healthy Skin Needs Natural Mineral Makeup 
Date:
March 25, 2008 11:47 AM
For those of you women who want healthy skin but can’t seem to go without a little blush and eye shadow, there’s makeup made from pure minerals that can present your face a natural alternative to the drugstore cosmetics. This mineral makeup opens up a world of makeup that is both natural and stylish. There are five main reasons to begin using mineral makeup immediately. First of all, mineral makeup lets your skin breathe. Regular makeup can lead to ugly breakouts for a lot of women. This is because a woman’s skin can be very picky about what is put on it. Anything that is too heavy will block pores and potentially lead to pimple development. Mineral makeup is extremely light, which makes it a popular option among women with sensitive skin. This lightness also means that you can occasionally wear the makeup to bed without paying the price the following morning. However, it is not suggested that you wear the makeup to bed. Mineral makeup feels better than regular makeup. Some makeup formulations can leave you feeling extremely oily. A lot of women who use mineral makeup are finding that the uncomfortable mask-like greasy feel of traditional makeup is not there. Without the mineral oils, talc, and other weighty ingredients that are found in traditional makeup products, mineral makeup is a lot more comfortable. If your complexion is oily to begin with, mineral-based products are especially helpful. Thirdly, mineral makeup is better for your health. Although your skin is a great barrier to the outside world, it isn’t totally immune from impurities. You can and do absorb a good amount of stuff through your skin, including the chemical ingredients that are found in regular makeup such as alcohol, dyes, fragrances, and fillers. Mineral makeup is made up of mostly finely pulverized minerals and natural coloring agents. Zinc is a common ingredient, as it soothes red, inflamed skin, and provides protection against the sun’s UV rays. Mineral makeup also helps you to avoid infections. This is a lesser known, but definitely appealing fact. Regular makeup can become a Petri dish for microorganisms such as bacteria, mold, and yeast. By nature, minerals are inorganic and therefore, are a lot less likely to breed these microorganisms. However, that assumes that you follow beauty hygiene basics like washing your hands before working on your face, using clean brushes, and maintaining a reasonably sanitary area to store your cosmetics. Lastly, mineral makeup allows you to look your best. Most of you are probably thinking that it is nice that mineral makeup won’t ruin your skin, but will it really do what it’s suppose to do in the first place as a makeup. The answer is yes. Minerals refract light, which gives your face a glow while still making crow’s feet, fine lines, and wrinkles less noticeable. Many brands also supply a complete line of products, which include blush, Bronzer, concealer, eye color, and foundation. This allows you to achieve a full range of skin effects. To use mineral makeup, it is best to apply it in very sheer layers. To learn more about mineral makeup, contact your local health food store.
(https://vitanetonline.com:443/forums/Index.cfm?CFApp=1&Message_ID=1728) Glycerylphosphorylcholine -- Supports Cognitive Function in AD ... 
Date:
May 24, 2005 09:52 AM
Cognitive Improvement in Mild to Moderate Alzheimer's Dementia After Treatment with the Acetylcholine Precursor Choline Alfoscerate: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial Maria De Jesus Moreno Moreno, MD Instituto Nacional de la Senectud, Mexico City, Mexico
in both men and woman they consistently improved after 90 and 180 days versus baseline with adiministration of GPC three times a day, whereas in the placebo group they remained unchanged or worsened. Statistically significant differences were observed between treatments after 90 and 180 days. Keypoints: references: Bartus RT, Dean RL III, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction, Science. 1982;217:408-414. 2. Larson EB, Kukull WA, Katzman RL. Cognitive impairment: Dementia and Alzheimer's disease. Annu Rev Public Health. 1992;13:431-449. 3. Hofman A, Rocca WA, Brayne C, et al, for the European Prevalence Research Group. The prevalence of dementia in Europe: A collaborative study of 1980-1990 findings. Int d Epidemiol. 1991;20:736-748. 4. Blackwood W, Corsellis JAN, eds. Greenfield's Neuropathology. 3rd ed. London: Arnold; 1976. 5. Geldmacher DS. Cost-effective recognition and diagnosis of dementia. 5emin Neurol. 2002;22:63-70. 6. Perry EK, Tomlinson BE, Blessed G, et al. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ. 1978;2:1457-1459. 7. Perry EK. The cholinergic hypothesis--ten years on. Br Med Bull. 1986;42:63-69. 8. Giacobini E. From molecular structure to Alzheimer therapy. Jpn d Pharmacol. 1997;74:225-241. 9. Giacobini E. Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: From tacrine to future applications. Neurochem Int. 1998;32:413-419. 10. Brinkman SD, Smith RC, Meyer JS, et al. Lecithin and memory training in suspected Alzheimer's disease. J Gerontol. 1982;37:4-9. 11. Davis E, Emmerling MR, Jaen JC, et al. Therapeutic intervention in dementia. Crit Rev Neurobiol. 1993;7:41-83. 12. Amenta E Parnetti L, Gallai V, Wallin A. Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropiate approaches? Mech Ageing Dev. 2001;122:2025-2040. 13. Sigala S, Imperato A, Rizzonelli P, et al. k-Alpha-glycerylphosphorylcholine antagonizes scopolamine-induced amnesia and enhances hippocampal cholinergic transmission in the rat. Eurd Pharmacol. 1992;211:351-358. 14. Govoni S, Battaini E Lucchi L, et al. Effects of alpha-glycerylphosphorylcholine in counteracting drug-induced amnesia: Through cholinergic and non-cholinergic mechanisms [in Italian]. Basi Raz Ter. 1991;21:75-78. 15. Canonico PL, Nicoletti F, Scapagnini U. Neurochemical and behavioral effects of alpha-glycerylphosphorylcholine [in Italian]. Basi Raz Te~ 1990;20: 53-54. 191 CLINICAL THERAPEUTICS ® 16. Parnetti L, Amenta E Gallai V. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: An analysis of published clinical data. Mech Ageing Dev. 2001;122:2041-2055. 17. Venn RD. The Sandoz Clinical Assessment-Geriatric (SCAG) scale. A general-purpose psychogeriatric rating scale. Gerontology. 1983;29:185-198. 18. Di Perri R, Coppola G, Ambrosio LA, et al. A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cytosine diphosphocholine in patients with vascular dementia. J Int Med Res. 1991;19:330-341. 19. Frattola L, Piolti R, Bassi S, et al. Multicenter clinical comparison of the effects of choline alphoscerate and cytidine diphosphocholine in the treatment of multi-infarct dementia. Curt Ther Res Clin Exp. 1991;49:683-693. 20. Muratorio A, Bonuccelli U, Nuti A, et al. A neurotropic approach to the treatment of multi-infarct dementia using L-c~-glycerylphosphorylcholine. Curt Ther Res Clin Exp. 1992;52:741-75l. 21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: APA; 1994. 22. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944. 23. Folstein ME Folstein SE. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198. 24. Loeb C, Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia. Stroke. 1983;14:399-401. 25. Hamilton M. A rating scale for depression.J Neurol Neurosurg Psychiatry. 1960;23:56-62. 26. Hamilton M. Development of a rating scale for primary depressive illness. BrJ Soc Clin Psych& 1967;6:278-296. 27. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. AmJ Psychiatry. 1984;141:1356-1364. 28. Reisberg B, Ferris SH, De Leon MJ, et al. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136-1139. 29. National Institute of Mental Health. Clinical global impressions. In: Guy W, ed. ECDEU Assessment for Psychopharmacology. Revised edition. Rockville, Md: National Institute of Mental Health; 1976:217-222. 30. Burns A, Russell E, Page S. New drugs for Alzheimer's disease. Br J Psychiatry. 1999;174:476-479. 31. Kumar V, Anand R, Messina J, et al. An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors. Eur J Neurol. 2000;7:159-169. 32. Knapp MJ, Knopman DS, Solomon PR, et al, for the Tacrine Study Group. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA. 1994;271:985-991. 192 M. Moreno 33. Lindstrom MJ, Bates DM. Newton-Rapshon algorithms for linear-mixed effects models for repeated measure data. J Am Stat Assoc. 1998;83:1014-1022. 34. Thai LJ, Carta A, Clarke WR, et al. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology 1996;47:705-711. 35. Rogers SL, Friedhoff LT, for the Donepezil Study Group. The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial. Dementia. 1996;7:293-303. 36. Rogers SL, Doody RS, Mohs RC, Friedhoff LT, for the Donepezil Study Group. Donepezil improves cognition and global function in Alzheimer disease: A 15-week, double-blind, placebo-controlled study. Arch Intern Med. 1998; 158:1021-1031. 37. Corey-Bloom J, Anand R, Veach J, for the ENA 713 B352 Study Group. A randomized trial evaluating the efficacy and the safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease. Int J Geriatr Psychopharmacol. 1998;1:55-65. 38. Rosler M, Anand R, Cicin-Sain A, et al. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial. BMJ. 1999;318: 633-638. 39. Amenta E Bronzetti E, Del Valle M, Vega JA. Effects of alpha-glycerylphosphorylcholine in neuroanatomy of aging brain in experimental animals [in Italian]. Basi Raz Te~: 1990;20:31-38. Address correspondence to: Scientific Department, Italfarmaco SpA, via dei Lavoratori 54, 20092 Cinisello Balsamo, Milan, Italy.
(https://vitanetonline.com:443/forums/Index.cfm?CFApp=1&Message_ID=98) | ||||||||||||||||||||||||
Nuts have always been touted as foods for the brain. Organic almonds are different from other nuts because it is not even a nut in the first place. It is a drupe that contains a large seed, which is sold and consumed exactly like other nuts. These seeds contain an abundance of nutrients, such as magnesium, phosphorus, iron, B vitamins, and many others, all of which work hand in hand in increasing neuronal activities in the brain and the central nervous system, thereby enhancing mental performance. 
